Status:
UNKNOWN
Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)
Lead Sponsor:
Medstar Health Research Institute
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Heparin-Induced Thrombocytopenia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate a scoring tool to help determine the presence of Heparin Induced Thrombocytopenia (HIT), which is an adverse reaction to heparin. We hypothesize that this scor...
Detailed Description
HIT is an immune response to heparin that can result in thrombogenic thrombocytopenia. It is often a difficult diagnosis to make, and its diagnosis is dependent upon both clinical and serologic criter...
Eligibility Criteria
Inclusion
- Patients with suspected HIT.
Exclusion
- None.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00946400
Start Date
August 1 2009
Last Update
July 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010